I am not into drugs very much but QCOR looks good. 

QCOR is a company with no debt and has a high probability of doing well in the face of the economic roller coaster (both up and down) we currently face.

The company markets drugs, including for Multiple Sclerosis.

Here is its profile.

Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company’s primary product is H.P. Acthar Gel (repository corticotropin injection) (Acthar), an injectable drug that is approved by the United States Food and Drug Administration, for the treatment of 19 indications. As of December 31, 2011, H.P. Acthar Gel was approved for the treatment of acute exacerbations of multiple sclerosis in adults, and as monotherapy for the treatment of infantile spasms in infants and children under two years of age. It is also indicated to induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus, as well as indicated for the treatment of a number of other diseases and disorders. Its other product is Doral (quazepam), which is indicated for the treatment of insomnia.